Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Systemic autoimmunity caused by fas deficiency in macrophages: a new perspective on the first identified autoimmunity gene.

Mountz JD, Li J, Hsu HC.

Arthritis Rheum. 2012 Mar;64(3):609-12. doi: 10.1002/art.34321. No abstract available.

2.

Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice.

Cuda CM, Agrawal H, Misharin AV, Haines GK 3rd, Hutcheson J, Weber E, Schoenfeldt JA, Mohan C, Pope RM, Perlman H.

Arthritis Rheum. 2012 Mar;64(3):808-20. doi: 10.1002/art.34317.

3.

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.

Siegel RM, Chan FK, Chun HJ, Lenardo MJ.

Nat Immunol. 2000 Dec;1(6):469-74. Review.

PMID:
11101867
4.

Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity.

De Maria R, Testi R.

Immunol Today. 1998 Mar;19(3):121-5. Review.

PMID:
9540271
5.

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

Benkerrou M, Le Deist F, de Villartay JP, Caillat-Zucman S, Rieux-Laucat F, Jabado N, Cavazzana-Calvo M, Fischer A.

Eur J Immunol. 1997 Aug;27(8):2043-7.

PMID:
9295043
6.

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.

Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, DiFranco D, Priori R, Conti F, Dianzani I, Valesini G, Merletti F, Dianzani U.

Blood. 2000 May 15;95(10):3176-82.

7.

CD95/CD95L interactions and their role in autoimmunity.

Ricci-Vitiani L, Conticello C, Zeuner A, De Maria R.

Apoptosis. 2000 Nov;5(5):419-24. Review.

PMID:
11256883
8.

Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.

Hutcheson J, Scatizzi JC, Siddiqui AM, Haines GK 3rd, Wu T, Li QZ, Davis LS, Mohan C, Perlman H.

Immunity. 2008 Feb;28(2):206-17. doi: 10.1016/j.immuni.2007.12.015.

9.

The role of fas ligand in vivo as a cause and regulator of pathogenesis.

Sabelko-Downes KA, Russell JH.

Curr Opin Immunol. 2000 Jun;12(3):330-5. Review.

PMID:
10781398
10.

Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.

Kobata T, Takasaki K, Asahara H, Hong NM, Masuko-Hongo K, Kato T, Hirose S, Shirai T, Kayagaki N, Yagita H, Okumura K, Nishioka K.

Immunology. 1997 Oct;92(2):206-13.

11.

Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

O'Reilly LA, Hughes P, Lin A, Waring P, Siebenlist U, Jain R, Gray DH, Gerondakis S, Strasser A.

Cell Death Differ. 2015 May;22(5):767-78. doi: 10.1038/cdd.2014.168. Epub 2014 Oct 31.

12.

Fas and Fas ligand in autoimmunity.

Rifkin IR, Marshak-Rothstein A.

Curr Dir Autoimmun. 1999;1:31-55. Review. No abstract available.

PMID:
11791447
13.

Role of inherited defects decreasing Fas function in autoimmunity.

Dianzani U, Chiocchetti A, Ramenghi U.

Life Sci. 2003 May 9;72(25):2803-24. Review.

PMID:
12697265
14.

Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.

Mabrouk I, Buart S, Hasmim M, Michiels C, Connault E, Opolon P, Chiocchia G, Lévi-Strauss M, Chouaib S, Karray S.

Immunity. 2008 Dec 19;29(6):922-33. doi: 10.1016/j.immuni.2008.10.007. Epub 2008 Nov 13.

15.

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.

Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I.

Haematologica. 2017 Feb;102(2):364-372. doi: 10.3324/haematol.2015.138081. Epub 2016 Oct 20.

16.

Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

de Villartay JP, Rieux-Laucat F, Fischer A, Le Deist F.

Springer Semin Immunopathol. 1998;19(3):301-10. Review. No abstract available.

PMID:
9540158
17.

Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.

Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R.

Leukemia. 1998 Apr;12(4):486-92.

PMID:
9557605
18.

Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.

Izawa T, Kondo T, Kurosawa M, Oura R, Matsumoto K, Tanaka E, Yamada A, Arakaki R, Kudo Y, Hayashi Y, Ishimaru N.

PLoS One. 2012;7(12):e48798. doi: 10.1371/journal.pone.0048798. Epub 2012 Dec 12.

19.

Activation-induced cell death in T cells and autoimmunity.

Zhang J, Xu X, Liu Y.

Cell Mol Immunol. 2004 Jun;1(3):186-92. Review.

20.

APO-1/Fas receptor (CD95) is non-functionally expressed in acute promyelocytic leukemias.

Rumi C, Rutella S, Lucia BM, Teofili L, De Stefano V, Leone G.

Eur J Histochem. 1997;41 Suppl 2:43-4. No abstract available.

PMID:
9859776

Supplemental Content

Support Center